Zurich Cantonal Bank
DFTX

Zurich Cantonal Bank’s Definium Therapeutics DFTX Stock Holding History

Zurich Cantonal Bank’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$394K Buy
20,868
+5,751
+38% +$97.6K ﹤0.01% 1947
2025
Q4 		$202K Hold
15,117
– – ﹤0.01% 2218
2025
Q3 		$178K Sell
15,117
-485
-3% -$4.52K ﹤0.01% 2245
2025
Q2 		$101K Sell
15,602
-13,265
-46% -$87.2K ﹤0.01% 2376
2025
Q1 		$169K Buy
28,867
+1,669
+6% +$12K ﹤0.01% 2180
2024
Q4 		$189K Buy
27,198
+4,972
+22% +$34.2K ﹤0.01% 2173
2024
Q3 		$126K Buy
22,226
+4,079
+22% +$28.4K ﹤0.01% 2337
2024
Q2 		$131K Buy
+18,147
New +$159K ﹤0.01% 2253

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Zurich Cantonal Bank's DFTX Position: Q1 2026 in Review

Zurich Cantonal Bank increased its Definium Therapeutics (DFTX) stake by 38% in Q1 2026, buying an estimated $97.6K and bringing the position to 20,868 shares worth $394K. The position accounts for ﹤0.01% of the portfolio, ranked #1947.

Zurich Cantonal Bank first reported a position in DFTX in Q2 2024 and has held it in 8 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Zurich Cantonal Bank held 20,868 shares of Definium Therapeutics worth $394K as of Q1 2026.
  • Zurich Cantonal Bank bought 5,751 Definium Therapeutics shares in Q1 2026, an estimated $97.6K.
  • Definium Therapeutics made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #1947 holding.
  • Zurich Cantonal Bank first reported a position in Definium Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.